A diagnostic dilemma: Chronic myelomonocytic leukemia versus atypical chronic myeloid leukemia

Acta Haematologica

Volumn 98, Issue 4, 1997, Pages 221-227

  Misialek, Michael J ^a   Pechet, Liberto ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Atypical chronic myeloid leukemia; Chronic myelomonocytic leukemia; Myelodysplastic syndrome

Indexed keywords

AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER RESEARCH; CASE REPORT; CHROMOSOME ABERRATION; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL FEATURE; CYTOCHEMISTRY; DIFFERENTIAL DIAGNOSIS; HUMAN; MALE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE;

EID: 0030856797     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000203629     Document Type: Article

References (25)

1. KoefTler HP: Introduction: Myelodysplastic syndromes. Semin Hematol 1996:33:87-94.
2. Rosati S, Anastasi J, Vardiman J: Recurring diagnostic problems in the pathology of the myelodysplastic syndromes. Semin Hematol 1996;33:111-126.
3. Kouides PA, Bennett JM: Morphology and classification of the myelodysplastic syndromes and their pathologic variants. Semin Hematol 1996;33:95-110.
4. Verhoef GEG, Pittaluga S, Wolf-Peeters CD, Boogaerts MA: FAB classification of myelodysplastic syndromes: Merits and controversies. Ann Hematol 1995;71:3-11.
5. Galton DAG: Hacmatological differences between chronic granulocytic leukemia, atypical chronic myeloid leukaemia, and chronic my-elomonocytic leukaemia. Leuk Lymphoma 1992;7:343-350.
6. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick H, Sultan C, Cox C: The chronic myeloid leukaemias: Guidelines for distinguishing chronic granulocytic, atyp-cial chronic myeloid, and chronic myelomono-cytic leukaemia: Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol 1994;87:746-754.
7. Bennett JM, Catovsky D. Daniel MT. Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51: 189-199.
8. Michaux JL, Martiat P: Chronic myelomono-cytic leukaemia (CMML) - A myelodysplastic or myeloproliferative syndrome? Leuk Lymphoma 1993;9:35-41.
9. Shepherd PC, Ganesan TS, Galton DA: Hae-matological classification of the chronic myeloid leukaemias. Baillicrcs Clin Haematol 1987;1:887-906.
10. Farhi DC: Myelodysplastic syndromes and acute myeloid leukemia. Diagnostic criteria and pitfalls (review). Pathol Ann 1995,30:29-57.
11. Ho PJ, Gibson J, Vincent P, Joshua D: The myelodysplastic syndromes: Diagnostic criteria and laboratory evaluation. Pathology 1993; 25:297-304.
12. Groupe Français de Cytogénétiquc Hématologique: Chronic myelomonocytic leukemia: Single entity or heterogeneous disorder? A prospective multicenter study of 100 patients. Cancer Genet Cytogenet 1991;55:57-65.
13. Nowell PC: Chromosome abnormalities in myelodysplastic syndromes. Semin Oncol 1992;19:25-33.
14. Fenaux P, Morel P, Lai JL: Cytogenetics of myelodysplastic syndromes. Semin Hematol 1996;33:127-138.
15. Tcfferi A, Hoagland HC, Thcrneau TM, Pierre RV: Chronic myelomonocytic leukemia: Natural history' and prognostic determinants. Mayo Clin Proc 1989;64:1246-1254.
16. Hirsch-Ginsbcrg C, LeMaistre AC, Kantarjian H. Talpaz M, Cork A, Freireich EJ, Trujillo JM, Lee MS, Stass SA: RAS mutations arc rare events in Philadelphia chromosome-negative/ bcr gene rearrangement-negative chronic myelogenous leukemia, but are prevalent in chronic myelomonocytic leukemia. Blood 1990;76:1214-1219.
17. Cogswell PC. Mogan R, Dunn M, Neubauer A, Nelson P, Poland-Johnston NK, Sandberg AA, Liu E: Mutations of the ras protooncogenes in chronic myelogenous leukemia: A high frequency of ras mutations in bcr/abl rearrangement-negative chronic myelogenous leukemia. Blood 1989;74:2629-2633.
18. Heim S, Mitelman F: Cancer Cytogenetics. New York, Wiley-Liss, 1995.
19. Mitelman F: Catalog of Chromosome Aberrations in Cancer. New York, Wiley-Liss, 1991.
20. Sellcri L, Emilia G, Luppi M, Temperani P, Zucchini P. Tagliafico E, Artusi T, Sarti M, Donelli A, Castoldi GL: Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and ‘bcr negative’. Hematol Pathol 1990,4:67-77.
21. Kurzrock R, Kantarjian HM, Shtalrid M, Gut-terman JU, Talpaz M: Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: A chronic myeloid leukemia with a distinct clinical course. Blood 1990;75:445-452.
22. Wiedemann LM, Karhi K, Shivji MKK, Ray-ter SI, Pegram SM, Dowden G, Bevan D, Will A, Galton DAG, Chan LC: The correlation of breakpoint cluster region rearrangement and p210phl/abl expression with morphological analysis of ph-negative chronic myeloid leukemia and other myeloproliferative diseases. Blood 1988;71:349-355.
23. Kantarjian HM, Shtalrid M, Kurzrock R, Blick M, Dalton WT, LeMaistre A, Stass SA, McCre-die KB, Gutterman J, Freireich EJ, Talpaz M: Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. Am J Med 1988;85:639-644.
24. Martiat P, Michaux JL, Rodhain J: Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): Comparison with Ph+ CML and chronic myelomonocytic leukemia. Blood 1991;78:205-211.
25. Third MIC Cooperative Study Group: Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders. Cancer Genet Cytogenet 1988;32: 1-10.